Cardalis 5 mg (Benazepril Hydrochloride TABLET (CHEWABLE)) 5 MG

Cardalis 5 mg chewable tablets contain benazepril hydrochloride, a medication used to manage heart conditions in pets. Ideal for pet owners seeking effective cardiovascular support.

Strength

5 MG

Manufacturer / TM Owner

CEVA ANIMAL HEALTH INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cardalis 5 mg chewable tablets are primarily used for managing heart conditions in pets, such as heart failure or high blood pressure. Pet owners often use this medication to support their pet's cardiovascular health. The active ingredient, benazepril hydrochloride, helps to regulate blood pressure and improve heart function.

Side Effects

Common effects of Cardalis 5 mg chewable tablets may include improved heart function and reduced symptoms of heart-related issues. Some pets may experience mild side effects, but these are generally temporary and should be monitored by a veterinarian.

Precautions & Warnings

Cardalis 5 mg chewable tablets should be stored in a cool, dry place away from direct sunlight. Always follow the dosage instructions provided by your veterinarian to ensure the safety and well-being of your pet. Avoid giving this medication to pets with known allergies to benazepril hydrochloride.

Avoid Interactions

Cardalis 5 mg chewable tablets may interact with other medications, including diuretics, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antibiotics. It is important to inform your veterinarian about all medications your pet is currently taking to avoid potential interactions.

Frequently Asked Questions

Cardalis 5 mg chewable tablets are used to manage heart conditions in pets, such as heart failure or high blood pressure.

Cardalis 5 mg chewable tablets should be given orally, following the dosage instructions provided by your veterinarian.

Common side effects may include mild gastrointestinal upset, lethargy, or changes in appetite. Consult your veterinarian if these effects persist or worsen.

Cardalis 5 mg may interact with other medications, so it is important to consult your veterinarian before combining it with other treatments.

Store Cardalis 5 mg chewable tablets in a cool, dry place away from direct sunlight and out of reach of children and pets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.